Joseph Bateman
@BatemanLab
Followers
910
Following
711
Media
48
Statuses
544
Professor of Molecular Neuroscience at King's College London. Studying the molecular basis of neurological disease. All things mitochondria and mTOR.
London, England
Joined August 2015
I am looking for a Research Assistant for a 10 month position in my lab. The RA will support several ongoing projects primarily using Drosophila models but also iPSC/organoid models of rare disease. @KingsIoPPN
https://t.co/JtPQuqHhss
0
1
3
Great to see this published and thanks to all 42 co-authors! Including @SilaUltanir @jansen_ac @palneurolab @UKTSA @CellsigL
🚀Check out this recent publication from the mTOR Pathway Diseases node - Challenges and opportunities from bench to bedside and the mTOR node https://t.co/K3diRJ1oS5
@BatemanLab @CharlotteRTye
1
3
4
MSCA International Training Program MENTOR, European PhD Network focused on mTOR pathophysiology. Apply to one of the 18 open PhD positions!
Undergraduate students passionate about growth and metabolism, please apply @mentor_program_ , the first @MSCActions on mTOR pathophysiology:
0
11
28
Great to be collaborating on this! @KingsIoPPN @RDRUKHub
We’re delighted to announce a new partnership between Oxford StemTech, @KingsCollegeLon, and MaxWell Biosystems, funded by @Innosuisse. Many patients with #epilepsy struggle with limited treatment options to manage their seizures effectively. To address this, our collaboration
0
1
1
👏🧠A new partnership between @KingsCollegeLon (@BatemanLab) , OxfordStemTech and @mxwbio has received funding from @InnovateUK to create a high-throughput drug testing platform to address limited treatment options for epilepsy #PrecisionMedicine #iPSC #organoids #Neuroscience
0
1
0
Save the date for the TOR de France international meeting in Nice, the 9 and 10 october 2025! TOR focussed, yet interdisciplinary! https://t.co/X9jqYlJaok
0
1
3
🧲Ready to make a real difference in research and advocacy? 📡By listening, sharing, and working together, we can better address the challenges faced in rare disease research 🌟Join us for our free webinar on Introduction to Co-Production! Register now🔗 https://t.co/84qKALuN2i
0
8
6
📢Registrations Now Open📢 🌟Join us for our 2nd Hybrid Annual Conference!🌟 💊inspiring keynote speakers 🪩lively panel discussions💥connect with others who are just as passionate about driving progress in rare disease research! 🔗 https://t.co/9bdcgwvPh6
0
3
6
Our lab's latest study, spearheaded by a fantastic colleague, Colleen, reveals that the blood glucose-lowering effect of metformin requires the inhibition of mitochondrial ETC complex I. https://t.co/iDMQNNiZOM. An insightful focus by Prof. Doug Green: https://t.co/U2p4pNtMgB
2
6
40
We had a brilliant time attending the mTOR Pathway Diseases node patient organisation workshop last week. Great to hear exciting updates from the #Research team and a great opportunity to connect with other patient orgs @BatemanLab @CharlotteRTye
The excellent @CharlotteRTye led our mTOR Pathway Diseases node patient organisation workshop last week. Thanks to everyone that attended @UKTSA @GoPI3Ks @ptenuki @LAMAction @myrovlytis @ChildGrowthUK
@EpilepsyInst @OrigamiCells. Supported by @The_MRC @NIHRresearch @RDRUKHub
0
3
2
A snippet from our day. I feel privileged to lead #PPI for the mTOR node and to learn so much from our patient organisation partners and lived experience experts- thank you for giving your time and helping our research grow. Watch this space! @KingsIoPPN
The excellent @CharlotteRTye led our mTOR Pathway Diseases node patient organisation workshop last week. Thanks to everyone that attended @UKTSA @GoPI3Ks @ptenuki @LAMAction @myrovlytis @ChildGrowthUK
@EpilepsyInst @OrigamiCells. Supported by @The_MRC @NIHRresearch @RDRUKHub
0
2
6
The excellent @CharlotteRTye led our mTOR Pathway Diseases node patient organisation workshop last week. Thanks to everyone that attended @UKTSA @GoPI3Ks @ptenuki @LAMAction @myrovlytis @ChildGrowthUK
@EpilepsyInst @OrigamiCells. Supported by @The_MRC @NIHRresearch @RDRUKHub
0
4
18
We have funding from the MND Association for a PhD studentship, starting in September 2025, if interested please see @FindAPhD
https://t.co/MGctGknjKY
findaphd.com
PhD Project - Identifying causes of neuronal cell death in C9orf72 repeat expansion toxicity at University College London, listed on FindAPhD.com
0
3
2
📢REGISTRATION NOW OPEN📢 🚨1st EpiGenRare Conference 🗓️26 March 2025 🏢Hyatt Regency, Manchester Please register your attendance for free using the link or QR code below https://t.co/7ZRJrkad6W
@smbanka @RDRUKHub
#RareDisease #rarediseaseresearch
0
5
9
It was a pleasure! Thanks for the invitation and stimulating discussions.
A huge thank you to @BatemanLab from King's College London, who gave a fantastic seminar on the 'Mechanistic insight into the role of mTOR signalling in rare neurological diseases' today as part of our lunchtime seminar series.
0
0
5
Incredibly excited to see our recent paper about the auto-regulation of #mTOR at #lysosomes featured on the cover of @MolecularCell 🤩🌍🎈 @DemetriadesLab Huge thanks to @sahola6 for so beautifully capturing the essence of our story in her artwork😍 👉🏼 https://t.co/DWf3i0090f
4
11
54
Application deadline for this is tomorrow!
Interested in researching neurodevelopmental disorders using iPSCs? Take a look at our iCASE PhD studentship, together with @NCNDgroup_KCL, to study mTORopathies https://t.co/XIMyxYXLBu
@KCL_MRCDTP @KingsIoPPN
https://t.co/fXs7EPU6u0
0
0
0
Meet iCASE student Mohua! Whilst you hear about what Mohua is researching, this is your reminder that applications for 2025 entry MRC DTP Studentships @KingsCollegeLon will close tomorrow at 13:00 GMT. Have you thought about applying yet? #MRCDTP25
0
1
0
We are working hard on the new mTOR pathway diseases registry together with the NDRS @NHSEngland. Get in touch if you want to know more. We are particularly keen to work with clinicians treating patients with these diseases. @RDRUKHub
The mTOR Diseases Pathway Node is helping us better understand rare diseases. This includes the world’s first registry for mTOR pathway conditions, including TSC. The registry has now launched, with TSC as the first of the 14 mTOR conditions selected to be added to the registry!
0
1
4